Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (2) , 261-269
- https://doi.org/10.1016/s0168-8278(00)00050-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hepatitis after intravenous buprenorphine misuse in heroin addictsJournal of Hepatology, 2001
- Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytesGastroenterology, 1998
- Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomesLife Sciences, 1997
- Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunctionGastroenterology, 1996
- Clinical pharmacology of buprenorphine: Ceiling effects at high dosesClinical Pharmacology & Therapeutics, 1994
- Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesionsHepatology, 1994
- Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondriaBiochemical Pharmacology, 1993
- Safety and side-effects of buprenorphine in the clinical management of heroin addictionDrug and Alcohol Dependence, 1990
- The systemic bioavailability of buprenorphine by various routes of administrationJournal of Pharmacy and Pharmacology, 1981
- BuprenorphineDrugs, 1979